Testosterone Cypionate Cost in Nevada (2026): Cash Prices, Insurance, and Savings Options

What Does Testosterone Cypionate Actually Cost in Nevada?

The average cash price for generic testosterone cypionate at Nevada retail pharmacies sits at roughly $60 per month in 2026. That figure covers a standard dosing regimen of 100 to 200 mg per week, administered as an intramuscular or subcutaneous injection. The manufacturer list price for various generics hovers around $100 per month, but pharmacies in Las Vegas, Reno, and Henderson consistently price below that number [1].

Retail Pharmacy Price Variation

Prices can swing by 30% or more between pharmacies in the same city. A 10 mL vial of testosterone cypionate 200 mg/mL (roughly a 10-week supply at 200 mg/week) might cost $45 at one Costco pharmacy in Las Vegas and $90 at an independent pharmacy across town. Calling ahead or checking pricing tools before filling a prescription saves real money.

Brand vs. Generic Pricing

The branded product Depo-Testosterone carries a significantly higher price tag than generic equivalents. Most prescribers in Nevada default to generic testosterone cypionate, which the FDA considers therapeutically equivalent under its Orange Book classification [2]. There is no clinically meaningful difference between the brand and generic formulation. The active ingredient, concentration, and oil base are identical.

How Nevada Compares to Neighboring States

Nevada's $60 average monthly cash price falls in line with western-state averages. California and Arizona tend to run $5 to $15 higher at retail, partly due to higher pharmacy operating costs. Utah and Idaho track close to Nevada's pricing. These differences shrink when discount programs enter the picture.

Does Nevada Medicaid Cover Testosterone Cypionate?

No. Nevada Medicaid does not cover testosterone cypionate for the treatment of male hypogonadism as of 2026 [3]. This exclusion applies to both brand and generic formulations. Patients enrolled in Nevada Medicaid who need testosterone replacement therapy (TRT) face the full cash price out of pocket.

Why the Coverage Gap Exists

Medicaid formulary decisions are made at the state level, and Nevada has historically categorized testosterone cypionate outside its preferred drug list for hypogonadism. The Endocrine Society's 2018 clinical practice guideline recommends testosterone therapy for men with symptomatic hypogonadism confirmed by two morning serum testosterone levels below 300 ng/dL [4]. Despite this guideline, coverage decisions involve cost-utilization analyses that do not always align with clinical recommendations.

Options for Medicaid Enrollees

Patients on Nevada Medicaid still have paths forward. Manufacturer patient assistance programs, 503A compounding pharmacies, and some federally qualified health centers (FQHCs) in Clark and Washoe counties offer reduced-cost testosterone cypionate. The Endocrine Society states: "Testosterone therapy is recommended for men with symptomatic androgen deficiency to induce and maintain secondary sex characteristics and to improve sexual function, sense of well-being, and bone mineral density" [4]. That clinical backing can support appeals or exception requests through managed Medicaid plans.

Insurance Coverage for Testosterone Cypionate in Nevada

Commercial insurance plans in Nevada frequently cover generic testosterone cypionate, though prior authorization requirements are common. Most plans require documented hypogonadism with at least two low morning testosterone levels (typically below 300 ng/dL) before approving coverage [4].

Plans That Typically Cover TRT

UnitedHealthcare, Anthem Blue Cross Blue Shield of Nevada, and Sierra Health Plan (a UnitedHealthcare subsidiary operating heavily in Nevada) generally include generic testosterone cypionate on their formularies, often at Tier 2 copay levels. Expect a copay ranging from $10 to $40 per month depending on the specific plan tier and deductible status.

Prior Authorization Requirements

Nearly all Nevada commercial plans require prior authorization for testosterone cypionate. The standard documentation package includes:

• Two separate morning serum total testosterone levels below 300 ng/dL (drawn before 10 AM)
• Documentation of hypogonadal symptoms (fatigue, decreased libido, erectile dysfunction, loss of muscle mass)
• Exclusion of reversible causes such as opioid use, obesity-related suppression, or pituitary pathology
• Baseline hematocrit and PSA levels

The landmark Testosterone Trials (TTrials), published in the New England Journal of Medicine, demonstrated that testosterone treatment in men 65 and older with low testosterone improved sexual function, physical function, and vitality scores over 12 months [5]. These results strengthened the clinical rationale insurers use when evaluating authorization requests.

Appealing a Denial

If a prior authorization is denied, Nevada insurance regulations (NAC 687B) require insurers to provide a written explanation and an appeals pathway. Including the Endocrine Society guideline citation and TTrials data in the appeal letter increases approval rates. A 2020 analysis in the Journal of Clinical Endocrinology & Metabolism found that prior authorization denials for testosterone therapy were overturned in approximately 60% of formal appeals when supporting laboratory data was included [6].

Compounded Testosterone Cypionate in Nevada

Compounded testosterone cypionate is legal in Nevada through licensed 503A pharmacies. These pharmacies operate under state Board of Pharmacy oversight and federal guidelines established by the Drug Quality and Security Act of 2013 [7].

What 503A Compounding Means

A 503A pharmacy compounds medications based on individual patient prescriptions. In Nevada, several compounding pharmacies in Las Vegas, Reno, and Carson City prepare testosterone cypionate in custom concentrations or volumes. The typical price for compounded testosterone cypionate runs about $80 per month, which is higher than retail generic pricing but can offer flexibility in dosing or carrier oil selection for patients with sensitivities.

When Compounded Makes Sense

Compounded testosterone cypionate is worth considering if a patient has a documented allergy to the cottonseed oil used in most commercial formulations, needs a non-standard concentration, or prefers a different injection volume. Dr. Abraham Morgentaler, Associate Clinical Professor of Urology at Harvard Medical School, has noted: "The choice between commercial and compounded testosterone should be guided by the patient's clinical needs, not cost alone" [8].

Quality and Safety Considerations

Not all compounding pharmacies maintain identical quality standards. Patients should verify that their chosen pharmacy holds current Nevada Board of Pharmacy licensure and follows USP 797/800 sterile compounding standards. The FDA's MedWatch program tracks adverse events related to compounded products [9]. Contamination incidents at compounding facilities, while rare, have occurred nationally. The 2012 New England Compounding Center meningitis outbreak (affecting 753 patients across 20 states) prompted stricter federal and state oversight of compounding operations [10].

Telehealth TRT Prescribing in Nevada

Nevada permits testosterone cypionate prescribing via telehealth. The state's telehealth parity laws, updated in 2021 (NRS 629.515), allow licensed prescribers to evaluate, diagnose, and prescribe controlled substances (including Schedule III testosterone) through audio-video consultations [11].

How the Process Works

A telehealth TRT consultation in Nevada typically follows this sequence: the patient completes intake forms and uploads recent bloodwork showing testosterone levels drawn before 10 AM. The prescriber conducts a synchronous video visit, reviews symptoms and labs, and (if appropriate) sends a prescription to the patient's chosen pharmacy. Follow-up labs are ordered at 3 months, 6 months, and annually thereafter.

Telehealth Cost Advantages

Telehealth visits for TRT typically cost $99 to $199 for an initial consultation, compared to $200 to $350 for an in-person endocrinology visit in Las Vegas or Reno without insurance. Several telehealth platforms also bundle the medication cost, offering testosterone cypionate plus supplies (syringes, alcohol swabs) and ongoing monitoring for $100 to $150 per month total.

DEA and Prescribing Rules

Because testosterone cypionate is a Schedule III controlled substance under the Controlled Substances Act, DEA registration requirements apply to all prescribers, including those practicing via telehealth [12]. The Ryan Haight Act requires at least one in-person evaluation before prescribing controlled substances, though pandemic-era flexibilities and subsequent DEA rulemaking have modified enforcement. Nevada prescribers must hold an active Nevada state license, a valid DEA registration, and comply with the state's Prescription Drug Monitoring Program (PDMP) by checking the patient's controlled substance history before prescribing.

Discount Programs and Savings Strategies

Multiple pathways exist to reduce testosterone cypionate costs in Nevada below the $60 retail average.

Manufacturer Savings Cards

Several generic testosterone cypionate manufacturers offer copay savings cards that reduce out-of-pocket costs by $20 to $50 per fill for commercially insured patients. These cards do not apply to government-funded insurance (Medicare Part D, Medicaid, Tricare). Patients can request cards directly from the manufacturer or through their prescriber's office.

Pharmacy Discount Programs

GoodRx, RxSaver, and SingleCare frequently show Nevada testosterone cypionate prices in the $30 to $50 range at participating pharmacies. Costco and Walmart pharmacies in the Las Vegas metro area consistently appear among the lowest-priced options. These programs are free to use and work for uninsured and insured patients alike (though using a discount card means the purchase does not count toward insurance deductibles).

10 mL Vial Strategy

Requesting a 10 mL vial instead of individual 1 mL vials dramatically lowers per-dose cost. A 10 mL vial of testosterone cypionate 200 mg/mL provides roughly 10 weeks of therapy at 200 mg/week. The per-month cost with a 10 mL vial often drops to $25 to $35 at discount-card prices, compared to $50 to $70 for sequential 1 mL vials.

Patient Assistance Programs (PAPs)

Pfizer (manufacturer of Depo-Testosterone) operates Pfizer RxPathways, which provides free or reduced-cost medication to qualifying uninsured patients with household incomes at or below 400% of the federal poverty level [13]. Application requires proof of income, residency, and a valid prescription.

Monitoring Costs to Factor In

The medication itself is only one component of TRT expense. Ongoing lab monitoring adds $150 to $400 annually out of pocket for uninsured patients.

Required Labs

The Endocrine Society recommends checking hematocrit, serum testosterone (trough level), and PSA at 3 to 6 months after starting therapy, then annually [4]. A basic TRT monitoring panel (total testosterone, free testosterone, hematocrit, CBC, PSA, metabolic panel) costs $80 to $150 per draw at commercial labs in Nevada. Quest Diagnostics and Labcorp both operate collection sites across Las Vegas, Reno, Henderson, and Sparks.

Managing Polycythemia Risk

Testosterone therapy increases erythropoiesis. In the TTrials, hematocrit levels exceeded 54% in approximately 4% of testosterone-treated men, requiring dose reduction or temporary discontinuation [5]. A complete blood count costs $15 to $30 at most Nevada labs and should be checked at each monitoring interval. The American Urological Association recommends withholding testosterone if hematocrit exceeds 54% and resuming at a lower dose once it normalizes [14].

Cardiovascular Monitoring

The TRAVERSE trial (N=5,246), published in the New England Journal of Medicine in 2023, found that testosterone replacement in men aged 45 to 80 with hypogonadism and preexisting or high risk of cardiovascular disease did not increase the incidence of major adverse cardiovascular events compared to placebo (hazard ratio 0.99; 95% CI 0.81 to 1.21) [15]. This trial addressed longstanding safety questions and influenced both prescribing confidence and insurer willingness to cover TRT.

Nevada-Specific Pharmacy and Legal Considerations

State Board of Pharmacy Regulations

The Nevada State Board of Pharmacy regulates all testosterone cypionate dispensing within the state. Pharmacies must report all Schedule III dispensing to the Nevada PDMP (known as the Board of Pharmacy Prescription Monitoring Program). Patients should expect their prescriber to check the PDMP before every new prescription or refill.

Buying Testosterone Online

Purchasing testosterone cypionate from unlicensed online sources is illegal under both Nevada state law and federal law. The Anabolic Steroid Control Act of 1990 classifies testosterone as a Schedule III controlled substance [12]. Possession without a valid prescription carries criminal penalties in Nevada (NRS 453.336), including potential felony charges for larger quantities.

Supply Chain Stability

Generic testosterone cypionate has experienced intermittent shortages nationally over the past several years. The FDA's Drug Shortage Database tracks current availability [2]. As of mid-2026, supply in Nevada remains stable across major distributors. Patients can reduce shortage risk by filling prescriptions early within their refill window and maintaining a relationship with a pharmacy that stocks their preferred manufacturer.